Phase Forward to Host Analyst Session at Its International Users Conference

• Press Release
• Source: Phase Forward Incorporated
• On 4:05 pm EDT, Wednesday October 28, 2009

WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward Incorporated (NASDAQ: PFWD - News), a leading provider of data management solutions for clinical trials and drug safety, announced today that it will be hosting an analyst session on Wednesday, November 4, 2009, in conjunction with the Phase Forward 8^th Annual International Users Conference in Boston, MA. The management team will discuss the Company’s market opportunity, product strategy, recent Clarix^TM IRT Solution release and the recent acquisition of Maaguzi Software.

Related Quotes

Symbol	Price	Change
PFWD	15.48	-0.43

{"s" : "pfwd","k" : "c10,l10,p20,t10","o" : "","j" : ""}

The Phase Forward presentation will begin at 1:00 p.m. Eastern Time and is expected to last approximately two hours. Phase Forward executives presenting at the event will include:

• Bob Weiler, Chairman, President and Chief Executive Officer
• Martin Young, Senior Vice President, Integration and Product Strategy
• Steve Rosenberg, Senior Vice President, Products and Services

The presentation will be webcast live and will be available by visiting the Investor Relations section of the website at www.phaseforward.com. The webcast will be archived on the Company’s website for 30 days after the presentation ends.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, SGS, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.

Public Relations
CHEN PR, Inc.
Barbara Heffner, 508-397-1138
bheffner@chenpr.com
or
Investor Relations
Integrated Corporate Relations
Timothy Dolan, 617-956-6727
tdolan@icrinc.com